Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3765178
Max Phase: Preclinical
Molecular Formula: C16H27NO4
Molecular Weight: 297.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3765178
Max Phase: Preclinical
Molecular Formula: C16H27NO4
Molecular Weight: 297.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C(CCCC)[C@@H](O)[C@H](C)C(=O)N1C(=O)OC[C@@H]1C(C)C
Standard InChI: InChI=1S/C16H27NO4/c1-6-7-8-11(4)14(18)12(5)15(19)17-13(10(2)3)9-21-16(17)20/h10,12-14,18H,4,6-9H2,1-3,5H3/t12-,13+,14+/m0/s1
Standard InChI Key: UCTKVLNRPOAFFR-BFHYXJOUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 297.40 | Molecular Weight (Monoisotopic): 297.1940 | AlogP: 2.73 | #Rotatable Bonds: 7 |
Polar Surface Area: 66.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.26 | CX LogD: 3.26 |
Aromatic Rings: 0 | Heavy Atoms: 21 | QED Weighted: 0.73 | Np Likeness Score: 0.90 |
1. Singh S, Gajulapati V, Gajulapati K, Goo JI, Park YH, Jung HY, Lee SY, Choi JH, Kim YK, Lee K, Heo TH, Choi Y.. (2016) Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers., 26 (4): [PMID:26810262] [10.1016/j.bmcl.2016.01.016] |
Source(1):